{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T04:44:26Z","timestamp":1791434666982,"version":"4.3.3"},"reference-count":170,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2019,3,19]],"date-time":"2019-03-19T00:00:00Z","timestamp":1552953600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007197","name":"U.S. Public Health Service","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007197","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Mol. Neurosci."],"DOI":"10.3389\/fnmol.2019.00068","type":"journal-article","created":{"date-parts":[[2019,3,19]],"date-time":"2019-03-19T01:01:15Z","timestamp":1552957275000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":72,"title":["Impaired Redox Signaling in Huntington\u2019s Disease: Therapeutic Implications"],"prefix":"10.3389","volume":"12","author":[{"given":"Bindu D.","family":"Paul","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Solomon H.","family":"Snyder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2019,3,19]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms3917","article-title":"A failure in energy metabolism and antioxidant uptake precede symptoms of Huntington\u2019s disease in mice.","volume":"4","author":"Acuna","year":"2013","journal-title":"Nat. Commun."},{"key":"B2","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/j.freeradbiomed.2018.04.002","article-title":"Brain mitochondrial iron accumulates in Huntington\u2019s disease, mediates mitochondrial dysfunction, and can be removed pharmacologically.","volume":"120","author":"Agrawal","year":"2018","journal-title":"Free Radic. Biol. Med."},{"key":"B3","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1111\/febs.14608","article-title":"Endoplasmic reticulum stress signalling - from basic mechanisms to clinical applications.","volume":"286","author":"Almanza","year":"2019","journal-title":"FEBS J."},{"key":"B4","doi-asserted-by":"publisher","first-page":"e4","DOI":"10.1016\/j.cels.2018.05.010","article-title":"High-throughput functional analysis distinguishes pathogenic, nonpathogenic, and compensatory transcriptional changes in neurodegeneration.","volume":"7","author":"Al-Ramahi","year":"2018","journal-title":"Cell Syst."},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1515\/revneuro-2018-0080","article-title":"Application of quercetin in neurological disorders: from nutrition to nanomedicine.","author":"Amanzadeh","year":"2019","journal-title":"Rev. Neurosci."},{"key":"B6","doi-asserted-by":"publisher","first-page":"3371","DOI":"10.1097\/00001756-200110290-00044","article-title":"Lipoic acid improves survival in transgenic mouse models of Huntington\u2019s disease.","volume":"12","author":"Andreassen","year":"2001","journal-title":"Neuroreport"},{"key":"B7","doi-asserted-by":"publisher","first-page":"133","DOI":"10.4103\/2394-8108.192519","article-title":"Creatine supplementation improves neural progenitor cell survival in Huntington\u2019s disease.","volume":"2","author":"Andres","year":"2016","journal-title":"Brain Circ."},{"key":"B8","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1007\/978-3-7091-0579-5_13","article-title":"Coenzyme Q10 serum levels in Huntington\u2019s disease.","volume":"68","author":"Andrich","year":"2004","journal-title":"J. Neural. Trans. Suppl."},{"key":"B9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.expneurol.2011.12.013","article-title":"Protein aggregates in Huntington\u2019s disease.","volume":"238","author":"Arrasate","year":"2012","journal-title":"Exp. Neurol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1016\/j.neuron.2015.10.038","article-title":"RAN translation in huntington disease.","volume":"88","author":"Banez-Coronel","year":"2015","journal-title":"Neuron"},{"key":"B11","doi-asserted-by":"publisher","first-page":"5037","DOI":"10.1073\/pnas.93.10.5037","article-title":"Expansion of polyglutamine repeat in huntingtin leads to abnormal protein interactions involving calmodulin.","volume":"93","author":"Bao","year":"1996","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B12","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1001\/archneur.56.5.569","article-title":"Increased basal ganglia iron levels in Huntington disease.","volume":"56","author":"Bartzokis","year":"1999","journal-title":"Arch. Neurol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"1655","DOI":"10.1007\/s11064-007-9352-7","article-title":"Myelin breakdown and iron changes in Huntington\u2019s disease: pathogenesis and treatment implications.","volume":"32","author":"Bartzokis","year":"2007","journal-title":"Neurochem. Res."},{"key":"B14","first-page":"821","article-title":"MRI evaluation of basal ganglia ferritin iron and neurotoxicity in Alzheimer\u2019s and Huntingon\u2019s disease.","volume":"46","author":"Bartzokis","year":"2000","journal-title":"Cell Mol. Biol."},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1038\/nrdp.2015.5","article-title":"Huntington disease.","volume":"1","author":"Bates","year":"2015","journal-title":"Nat. Rev. Dis. Prim."},{"key":"B16","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.nbd.2010.09.009","article-title":"Mitochondrial autophagy in neural function, neurodegenerative disease, neuron cell death, and aging.","volume":"43","author":"Batlevi","year":"2011","journal-title":"Neurobiol. Dis."},{"key":"B17","doi-asserted-by":"publisher","first-page":"4181","DOI":"10.1523\/JNEUROSCI.13-10-04181.1993","article-title":"Neurochemical and histologic characterization of striatal excitotoxic lesions produced by the mitochondrial toxin 3-nitropropionic acid.","volume":"13","author":"Beal","year":"1993","journal-title":"J. Neurosci."},{"key":"B18","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/0022-510X(92)90191-M","article-title":"Kynurenic acid concentrations are reduced in Huntington\u2019s disease cerebral cortex.","volume":"108","author":"Beal","year":"1992","journal-title":"J. Neurol. Sci."},{"key":"B19","doi-asserted-by":"publisher","first-page":"1929","DOI":"10.1007\/s00726-015-2165-0","article-title":"Creatine for neuroprotection in neurodegenerative disease: end of story?","volume":"48","author":"Bender","year":"2016","journal-title":"Amino Acids"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2017.00065","article-title":"New challenges to study heterogeneity in cancer redox metabolism.","volume":"5","author":"Benfeitas","year":"2017","journal-title":"Front. Cell Dev. Biol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1146\/annurev-biochem-060815-014556","article-title":"Mammalian autophagy: how does it work?","volume":"85","author":"Bento","year":"2016","journal-title":"Annu. Rev. Biochem."},{"key":"B22","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1016\/j.redox.2015.02.002","article-title":"Neonatal iron supplementation potentiates oxidative stress, energetic dysfunction and neurodegeneration in the R6\/2 mouse model of Huntington\u2019s disease.","volume":"4","author":"Berggren","year":"2015","journal-title":"Redox. Biol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"E11874","DOI":"10.1073\/pnas.1807305115","article-title":"Metabolic network-based stratification of hepatocellular carcinoma reveals three distinct tumor subtypes.","volume":"115","author":"Bidkhori","year":"2018","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B24","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1007\/s12640-012-9336-5","article-title":"Organoselenium bis selenide attenuates 3-nitropropionic acid-induced neurotoxicity in rats.","volume":"23","author":"Bortolatto","year":"2013","journal-title":"Neurotox. Res."},{"key":"B25","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.nbd.2010.04.007","article-title":"Cystamine and intrabody co-treatment confers additional benefits in a fly model of Huntington\u2019s disease.","volume":"40","author":"Bortvedt","year":"2010","journal-title":"Neurobiol. Dis."},{"key":"B26","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1212\/WNL.46.2.527","article-title":"Trinucleotide repeat length and clinical progression in Huntington\u2019s disease.","volume":"46","author":"Brandt","year":"1996","journal-title":"Neurology"},{"key":"B27","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.abb.2017.08.003","article-title":"Nuclear factor (erythroid-derived 2)-like 2 (NRF2) drug discovery: biochemical toolbox to develop NRF2 activators by reversible binding of Kelch-like ECH-associated protein 1 (KEAP1).","volume":"631","author":"Bresciani","year":"2017","journal-title":"Arch. Biochem. Biophys."},{"key":"B28","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1002\/ana.410410514","article-title":"Oxidative damage and metabolic dysfunction in Huntington\u2019s disease: selective vulnerability of the basal ganglia.","volume":"41","author":"Browne","year":"1997","journal-title":"Ann. Neurol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/j.expneurol.2010.04.008","article-title":"Cystamine protects from 3-nitropropionic acid lesioning via induction of nf-e2 related factor 2 mediated transcription.","volume":"224","author":"Calkins","year":"2010","journal-title":"Exp. Neurol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1007\/978-3-319-71779-1_3","article-title":"Mitochondrial dysfunction in huntington\u2019s disease.","volume":"1049","author":"Carmo","year":"2018","journal-title":"Adv. Exp. Med. Biol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1046\/j.1471-4159.2001.00461.x","article-title":"High-affinity sodium-vitamin C co-transporters (SVCT) expression in embryonic mouse neurons.","volume":"78","author":"Castro","year":"2001","journal-title":"J. Neurochem."},{"key":"B32","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1111\/j.1471-4159.2009.06151.x","article-title":"A metabolic switch in brain: glucose and lactate metabolism modulation by ascorbic acid.","volume":"110","author":"Castro","year":"2009","journal-title":"J. Neurochem."},{"key":"B33","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/j.bbrc.2007.05.093","article-title":"Increased oxidative damage and mitochondrial abnormalities in the peripheral blood of Huntington\u2019s disease patients.","volume":"359","author":"Chen","year":"2007","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0077023","article-title":"Iron accumulates in huntington\u2019s disease neurons: protection by deferoxamine.","volume":"8","author":"Chen","year":"2013","journal-title":"PLoS One"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1038\/srep18736","article-title":"Curcumin modulates cell death and is protective in huntington\u2019s disease model.","volume":"6","author":"Chongtham","year":"2016","journal-title":"Sci. Rep."},{"key":"B36","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1093\/hmg\/ddh162","article-title":"Mutant huntingtin directly increases susceptibility of mitochondria to the calcium-induced permeability transition and cytochrome c release.","volume":"13","author":"Choo","year":"2004","journal-title":"Hum. Mol. Genet."},{"key":"B37","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.neulet.2005.05.065","article-title":"Increased glutathione levels in cortical and striatal mitochondria of the R6\/2 Huntington\u2019s disease mouse model.","volume":"386","author":"Choo","year":"2005","journal-title":"Neurosci. Lett."},{"key":"B38","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1002\/emmm.201000102","article-title":"Mitochondrial fission and cristae disruption increase the response of cell models of Huntington\u2019s disease to apoptotic stimuli.","volume":"2","author":"Costa","year":"2010","journal-title":"EMBO Mol. Med."},{"key":"B39","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1016\/j.freeradbiomed.2015.09.024","article-title":"Beyond the redox imbalance: oxidative stress contributes to an impaired GLUT3 modulation in Huntington\u2019s disease.","volume":"89","author":"Covarrubias-Pinto","year":"2015","journal-title":"Free Radic. Biol. Med."},{"key":"B40","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.cell.2006.09.015","article-title":"Transcriptional repression of PGC-1alpha by mutant huntingtin leads to mitochondrial dysfunction and neurodegeneration.","volume":"127","author":"Cui","year":"2006","journal-title":"Cell"},{"key":"B41","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1016\/S0092-8674(00)80513-9","article-title":"Formation of neuronal intranuclear inclusions underlies the neurological dysfunction in mice transgenic for the HD mutation.","volume":"90","author":"Davies","year":"1997","journal-title":"Cell"},{"key":"B42","doi-asserted-by":"publisher","first-page":"10161","DOI":"10.1128\/MCB.24.23.10161-10168.2004","article-title":"Translational repression mediates activation of nuclear factor kappa B by phosphorylated translation initiation factor 2.","volume":"24","author":"Deng","year":"2004","journal-title":"Mol. Cell Biol."},{"key":"B43","doi-asserted-by":"publisher","first-page":"S94","DOI":"10.1002\/ana.410320716","article-title":"Alterations in levels of iron, ferritin, and other trace metals in neurodegenerative diseases affecting the basal ganglia. the royal kings and queens parkinson\u2019s disease research group.","volume":"32","author":"Dexter","year":"1992","journal-title":"Ann. Neurol."},{"key":"B44","doi-asserted-by":"publisher","first-page":"1990","DOI":"10.1126\/science.277.5334.1990","article-title":"Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain.","volume":"277","author":"DiFiglia","year":"1997","journal-title":"Science"},{"key":"B45","doi-asserted-by":"publisher","first-page":"3937","DOI":"10.1093\/hmg\/ddw234","article-title":"Huntingtin N17 domain is a reactive oxygen species sensor regulating huntingtin phosphorylation and localization.","volume":"25","author":"DiGiovanni","year":"2016","journal-title":"Hum. Mol. Genet."},{"key":"B46","doi-asserted-by":"publisher","first-page":"3576","DOI":"10.1111\/febs.14379","article-title":"The role of Nrf2 signaling in counteracting neurodegenerative diseases.","volume":"285","author":"Dinkova-Kostova","year":"2018","journal-title":"FEBS J."},{"key":"B47","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1111\/j.1750-3639.2008.00258.x","article-title":"Neuroprotective effects of calmodulin peptide 76-121aa: disruption of calmodulin binding to mutant huntingtin.","volume":"20","author":"Dudek","year":"2010","journal-title":"Brain Pathol."},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.3390\/ph11020044","article-title":"Old drugs as new treatments for neurodegenerative diseases.","volume":"11","author":"Duraes","year":"2018","journal-title":"Pharmaceuticals"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0016172","article-title":"Efficacy of fumaric acid esters in the R6\/2 and YAC128 models of huntington\u2019s disease.","volume":"6","author":"Ellrichmann","year":"2011","journal-title":"PLoS One"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-04256-w","article-title":"The stress response factor daf-16\/FOXO is required for multiple compound families to prolong the function of neurons with Huntington\u2019s disease.","volume":"7","author":"Farina","year":"2017","journal-title":"Sci. Rep."},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0090202","article-title":"Trehalose reverses cell malfunction in fibroblasts from normal and Huntington\u2019s disease patients caused by proteosome inhibition.","volume":"9","author":"Fernandez-Estevez","year":"2014","journal-title":"PLoS One"},{"key":"B52","doi-asserted-by":"publisher","first-page":"1592","DOI":"10.1523\/JNEUROSCI.22-05-01592.2002","article-title":"Therapeutic effects of coenzyme Q10 and remacemide in transgenic mouse models of Huntington\u2019s disease.","volume":"22","author":"Ferrante","year":"2002","journal-title":"J. Neurosci."},{"key":"B53","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1002\/mds.25717","article-title":"Multisource ascertainment of Huntington disease in Canada: prevalence and population at risk.","volume":"29","author":"Fisher","year":"2014","journal-title":"Mov. Disord."},{"key":"B54","doi-asserted-by":"publisher","first-page":"S22","DOI":"10.1002\/ana.410320706","article-title":"Free radical damage to protein and DNA: mechanisms involved and relevant observations on brain undergoing oxidative stress.","volume":"32","author":"Floyd","year":"1992","journal-title":"Ann. Neurol."},{"key":"B55","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1111\/j.1471-4159.2004.02726.x","article-title":"Cystamine increases L-cysteine levels in Huntington\u2019s disease transgenic mouse brain and in a PC12 model of polyglutamine aggregation.","volume":"91","author":"Fox","year":"2004","journal-title":"J. Neurochem."},{"key":"B56","doi-asserted-by":"publisher","first-page":"18320","DOI":"10.1074\/jbc.M110.199448","article-title":"Cysteine oxidation within N-terminal mutant huntingtin promotes oligomerization and delays clearance of soluble protein.","volume":"286","author":"Fox","year":"2011","journal-title":"J. Biol. Chem."},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0000334","article-title":"Mechanisms of copper ion mediated Huntington\u2019s disease progression.","volume":"2","author":"Fox","year":"2007","journal-title":"PLoS One"},{"key":"B58","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.neuint.2014.06.017","article-title":"Dysregulation of system xc(-) expression induced by mutant huntingtin in a striatal neuronal cell line and in R6\/2 mice.","volume":"76","author":"Frederick","year":"2014","journal-title":"Neurochem. Int."},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-60327-514-9","author":"Gadoth","year":"2011","journal-title":"Oxidative Stress and Free Radical Damage in Neurology."},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.95665","article-title":"Early pridopidine treatment improves behavioral and transcriptional deficits in YAC128 Huntington disease mice.","volume":"2","author":"Garcia-Miralles","year":"2017","journal-title":"JCI Insight"},{"key":"B61","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.redox.2013.12.013","article-title":"Autophagy as an essential cellular antioxidant pathway in neurodegenerative disease.","volume":"2","author":"Giordano","year":"2014","journal-title":"Redox Biol."},{"key":"B62","doi-asserted-by":"publisher","first-page":"e6","DOI":"10.1016\/j.neuron.2017.03.023","article-title":"Mutant huntingtin disrupts the nuclear pore complex.","volume":"94","author":"Grima","year":"2017","journal-title":"Neuron"},{"key":"B63","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1002\/ana.410390317","article-title":"Mitochondrial defect in Huntington\u2019s disease caudate nucleus.","volume":"39","author":"Gu","year":"1996","journal-title":"Ann. Neurol."},{"key":"B64","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1101\/gad.297374.117","article-title":"Physiological\/pathological ramifications of transcription factors in the unfolded protein response.","volume":"31","author":"Han","year":"2017","journal-title":"Genes Dev."},{"key":"B65","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1038\/aps.2018.11","article-title":"Proteostasis in Huntington\u2019s disease: disease mechanisms and therapeutic opportunities.","volume":"39","author":"Harding","year":"2018","journal-title":"Acta Pharmacol. Sin."},{"key":"B66","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1212\/WNL.0000000000004209","article-title":"The CREST-E study of creatine for huntington disease: a randomized controlled trial.","volume":"89","author":"Hersch","year":"2017","journal-title":"Neurology"},{"key":"B67","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1038\/nrneurol.2017.99","article-title":"ER stress and the unfolded protein response in neurodegeneration.","volume":"13","author":"Hetz","year":"2017","journal-title":"Nat. Rev. Neurol."},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1186\/1750-1326-7-12","article-title":"Improvement of neuropathology and transcriptional deficits in CAG 140 knock-in mice supports a beneficial effect of dietary curcumin in Huntington\u2019s disease.","volume":"7","author":"Hickey","year":"2012","journal-title":"Mol. Neurodegener."},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2013.170","article-title":"Sigma-1 receptor agonist PRE084 is protective against mutant huntingtin-induced cell degeneration: involvement of calpastatin and the NF-kappaB pathway.","volume":"4","author":"Hyrskyluoto","year":"2013","journal-title":"Cell Death Dis."},{"key":"B70","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1002\/ana.410360412","article-title":"Trinucleotide repeat length and rate of progression of Huntington\u2019s disease.","volume":"36","author":"Illarioshkin","year":"1994","journal-title":"Ann. Neurol."},{"key":"B71","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/j.ccr.2011.01.038","article-title":"CD44 variant regulates redox status in cancer cells by stabilizing the xCT subunit of system xc(-) and thereby promotes tumor growth.","volume":"19","author":"Ishimoto","year":"2011","journal-title":"Cancer Cell"},{"key":"B72","doi-asserted-by":"publisher","first-page":"2619","DOI":"10.1007\/s12035-015-9230-2","article-title":"Sulforaphane ameliorates 3-nitropropionic acid-induced striatal toxicity by activating the keap1-Nrf2-ARE pathway and inhibiting the MAPKs and NF-kappaB pathways.","volume":"53","author":"Jang","year":"2016","journal-title":"Mol. Neurobiol."},{"key":"B73","doi-asserted-by":"publisher","first-page":"2689","DOI":"10.1212\/WNL.43.12.2689","article-title":"Evidence for impairment of energy metabolism in vivo in Huntington\u2019s disease using localized 1H NMR spectroscopy.","volume":"43","author":"Jenkins","year":"1993","journal-title":"Neurology"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0057932","article-title":"Impaired mitochondrial dynamics and Nrf2 signaling contribute to compromised responses to oxidative stress in striatal cells expressing full-length mutant huntingtin.","volume":"8","author":"Jin","year":"2013","journal-title":"PLoS One"},{"key":"B75","doi-asserted-by":"publisher","first-page":"1865","DOI":"10.1089\/ars.2006.8.1865","article-title":"Redefining oxidative stress.","volume":"8","author":"Jones","year":"2006","journal-title":"Antioxid. Redox. Signal."},{"key":"B76","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1038\/nm0202-143","article-title":"Prolonged survival and decreased abnormal movements in transgenic model of Huntington disease, with administration of the transglutaminase inhibitor cystamine.","volume":"8","author":"Karpuj","year":"2002","journal-title":"Nat. Med."},{"key":"B77","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.neuint.2005.09.002","article-title":"Effect of coenzyme Q10 and vitamin E on brain energy metabolism in the animal model of Huntington\u2019s disease.","volume":"48","author":"Kasparova","year":"2006","journal-title":"Neurochem. Int."},{"key":"B78","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1146\/annurev.pharmtox.46.120604.141046","article-title":"Cell survival responses to environmental stresses via the Keap1-Nrf2-ARE pathway.","volume":"47","author":"Kensler","year":"2007","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"B79","doi-asserted-by":"publisher","first-page":"325","DOI":"10.5607\/en.2015.24.4.325","article-title":"The role of oxidative stress in neurodegenerative diseases.","volume":"24","author":"Kim","year":"2015","journal-title":"Exp. Neurobiol."},{"key":"B80","doi-asserted-by":"publisher","first-page":"1717","DOI":"10.1126\/science.290.5497.1717","article-title":"Autophagy as a regulated pathway of cellular degradation.","volume":"290","author":"Klionsky","year":"2000","journal-title":"Science"},{"key":"B81","doi-asserted-by":"crossref","first-page":"34","DOI":"10.32607\/20758251-2017-9-2-34-46","article-title":"Huntington\u2019s disease: calcium dyshomeostasis and pathology models.","volume":"9","author":"Kolobkova","year":"2017","journal-title":"Acta Nat."},{"key":"B82","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1038\/nature05778","article-title":"OGG1 initiates age-dependent CAG trinucleotide expansion in somatic cells.","volume":"447","author":"Kovtun","year":"2007","journal-title":"Nature"},{"key":"B83","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/j.molcel.2010.09.023","article-title":"Autophagy and the integrated stress response.","volume":"40","author":"Kroemer","year":"2010","journal-title":"Mol. Cell"},{"key":"B84","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1358\/mf.2007.29.1.1063492","article-title":"Possible neuroprotective mechanisms of curcumin in attenuating 3-nitropropionic acid-induced neurotoxicity.","volume":"29","author":"Kumar","year":"2007","journal-title":"Methods Find. Exp. Clin. Pharmacol."},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.1186\/s13024-018-0259-3","article-title":"Large-scale transcriptomic analysis reveals that pridopidine reverses aberrant gene expression and activates neuroprotective pathways in the YAC128 HD mouse.","volume":"13","author":"Kusko","year":"2018","journal-title":"Mol. Neurodegener."},{"key":"B86","doi-asserted-by":"publisher","first-page":"1338","DOI":"10.1038\/s41556-018-0235-8","article-title":"Autophagy and the cell biology of age-related disease.","volume":"20","author":"Leidal","year":"2018","journal-title":"Nat. Cell Biol."},{"key":"B87","doi-asserted-by":"publisher","first-page":"4552","DOI":"10.1523\/JNEUROSCI.5865-09.2010","article-title":"Aberrant Rab11-dependent trafficking of the neuronal glutamate transporter EAAC1 causes oxidative stress and cell death in Huntington\u2019s disease.","volume":"30","author":"Li","year":"2010","journal-title":"J. Neurosci."},{"key":"B88","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1111\/jnc.12647","article-title":"Sulforaphane enhances proteasomal and autophagic activities in mice and is a potential therapeutic reagent for Huntington\u2019s disease.","volume":"129","author":"Liu","year":"2014","journal-title":"J. Neurochem."},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.3010523","article-title":"Targeting ATM ameliorates mutant Huntingtin toxicity in cell and animal models of Huntington\u2019s disease.","volume":"6","author":"Lu","year":"2014","journal-title":"Sci. Transl. Med."},{"key":"B90","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.nbd.2014.06.022","article-title":"Altered selenium status in Huntington\u2019s disease: neuroprotection by selenite in the N171-82Q mouse model.","volume":"71","author":"Lu","year":"2014","journal-title":"Neurobiol. Dis."},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.1002\/jbt.21837","article-title":"Sulforaphane prevents quinolinic acid-induced mitochondrial dysfunction in rat striatum.","volume":"31","author":"Luis-Garcia","year":"2017","journal-title":"J. Biochem. Mol. Toxicol."},{"key":"B92","doi-asserted-by":"publisher","first-page":"1911","DOI":"10.1093\/hmg\/11.17.1911","article-title":"Dysregulation of gene expression in the R6\/2 model of polyglutamine disease: parallel changes in muscle and brain.","volume":"11","author":"Luthi-Carter","year":"2002","journal-title":"Hum. Mol. Genet."},{"key":"B93","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1016\/0092-8674(93)90585-E","article-title":"A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington\u2019s disease chromosomes. The huntington\u2019s disease collaborative research group.","volume":"72","author":"MacDonald","year":"1993","journal-title":"Cell"},{"key":"B94","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1093\/hmg\/ddw395","article-title":"Huntingtin is a scaffolding protein in the ATM oxidative DNA damage response complex.","volume":"26","author":"Maiuri","year":"2017","journal-title":"Hum. Mol. Genet."},{"key":"B95","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1038\/ng0297-197","article-title":"Instability of highly expanded CAG repeats in mice transgenic for the Huntington\u2019s disease mutation.","volume":"15","author":"Mangiarini","year":"1997","journal-title":"Nat. Genet."},{"key":"B96","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1038\/ng.2732","article-title":"Glutathione peroxidase activity is neuroprotective in models of Huntington\u2019s disease.","volume":"45","author":"Mason","year":"2013","journal-title":"Nat. Genet."},{"key":"B97","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1111\/ene.13413","article-title":"Huntington\u2019s disease: a clinical review.","volume":"25","author":"McColgan","year":"2018","journal-title":"Eur. J. Neurol."},{"key":"B98","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1212\/WNL.0000000000003478","article-title":"A randomized, double-blind, placebo-controlled trial of coenzyme Q10 in Huntington disease.","volume":"88","author":"McGarry","year":"2017","journal-title":"Neurology"},{"key":"B99","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1007\/s11010-015-2561-5","article-title":"Mitochondrial modulators improve lipid composition and attenuate memory deficits in experimental model of Huntington\u2019s disease.","volume":"410","author":"Mehrotra","year":"2015","journal-title":"Mol. Cell Biochem."},{"key":"B100","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1146\/annurev.bi.52.070183.003431","article-title":"Glutathione.","volume":"52","author":"Meister","year":"1983","journal-title":"Annu. Rev. Biochem."},{"key":"B101","doi-asserted-by":"publisher","first-page":"2893","DOI":"10.1093\/hmg\/ddw142","article-title":"RNA-Seq of Huntington\u2019s disease patient myeloid cells reveals innate transcriptional dysregulation associated with proinflammatory pathway activation.","volume":"25","author":"Miller","year":"2016","journal-title":"Hum. Mol. Genet."},{"key":"B102","doi-asserted-by":"publisher","DOI":"10.1371\/currents.hd.58d04209ab6d5de0844db7ef5628ff67","article-title":"Effects of anthocyanins on CAG repeat instability and behaviour in huntington\u2019s disease R6\/1 Mice.","author":"Mollersen","year":"2016","journal-title":"PLoS Curr."},{"key":"B103","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1042\/BJ20081386","article-title":"How mitochondria produce reactive oxygen species.","volume":"417","author":"Murphy","year":"2009","journal-title":"Biochem. J."},{"key":"B104","doi-asserted-by":"publisher","DOI":"10.1126\/scisignal.2000464","article-title":"H2S signals through protein S-sulfhydration.","volume":"2","author":"Mustafa","year":"2009","journal-title":"Sci. Signal."},{"key":"B105","doi-asserted-by":"publisher","first-page":"5385","DOI":"10.1007\/s12035-016-0048-3","article-title":"Comparative mitochondrial-based protective effects of resveratrol and nicotinamide in huntington\u2019s disease models.","volume":"54","author":"Naia","year":"2017","journal-title":"Mol. Neurobiol."},{"key":"B106","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1016\/j.mito.2010.04.007","article-title":"S-nitrosylation of Drp1 links excessive mitochondrial fission to neuronal injury in neurodegeneration.","volume":"10","author":"Nakamura","year":"2010","journal-title":"Mitochondrion"},{"key":"B107","doi-asserted-by":"publisher","first-page":"1166","DOI":"10.1139\/o90-173","article-title":"Cellular functions of ascorbic acid.","volume":"68","author":"Padh","year":"1990","journal-title":"Biochem. Cell Biol."},{"key":"B108","doi-asserted-by":"publisher","first-page":"2580","DOI":"10.1002\/j.1460-2075.1995.tb07256.x","article-title":"A novel signal transduction pathway from the endoplasmic reticulum to the nucleus is mediated by transcription factor NF-kappa B.","volume":"14","author":"Pahl","year":"1995","journal-title":"EMBO J."},{"key":"B109","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1016\/j.tips.2018.02.007","article-title":"Cysteine metabolism in neuronal redox homeostasis.","volume":"39","author":"Paul","year":"2018","journal-title":"Trends Pharmacol. Sci."},{"key":"B110","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1038\/nature13136","article-title":"Cystathionine gamma-lyase deficiency mediates neurodegeneration in Huntington\u2019s disease.","volume":"509","author":"Paul","year":"2014","journal-title":"Nature"},{"key":"B111","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1038\/nrm3391","article-title":"H(2)S signalling through protein sulfhydration and beyond.","volume":"13","author":"Paul","year":"2012","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"B112","doi-asserted-by":"publisher","first-page":"2491","DOI":"10.4161\/15384101.2014.950538","article-title":"Neurodegeneration in Huntington\u2019s disease involves loss of cystathionine gamma-lyase.","volume":"13","author":"Paul","year":"2014","journal-title":"Cell Cycle"},{"key":"B113","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1016\/j.tibs.2015.08.007","article-title":"H2S: a novel gasotransmitter that signals by sulfhydration.","volume":"40","author":"Paul","year":"","journal-title":"Trends Biochem. Sci."},{"key":"B114","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1089\/ars.2014.5917","article-title":"Modes of physiologic H2S signaling in the brain and peripheral tissues.","volume":"22","author":"Paul","year":"","journal-title":"Antioxid. Redox. Signal."},{"key":"B115","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.bcp.2017.11.019","article-title":"Gasotransmitter hydrogen sulfide signaling in neuronal health and disease.","volume":"149","author":"Paul","year":"2018","journal-title":"Biochem. Pharmacol."},{"key":"B116","doi-asserted-by":"publisher","first-page":"1258","DOI":"10.1016\/j.clinbiochem.2015.06.014","article-title":"Association of status redox with demographic, clinical and imaging parameters in patients with Huntington\u2019s disease.","volume":"48","author":"Pena-Sanchez","year":"2015","journal-title":"Clin. Biochem."},{"key":"B117","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1111\/j.1749-6632.2010.05634.x","article-title":"Oxidative stress caused by mitochondrial calcium overload.","volume":"1201","author":"Peng","year":"2010","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"B118","doi-asserted-by":"publisher","first-page":"1771","DOI":"10.1176\/ajp.152.12.1771","article-title":"Trial of d-alpha-tocopherol in Huntington\u2019s disease.","volume":"152","author":"Peyser","year":"1995","journal-title":"Am. J. Psychiatry"},{"key":"B119","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/S0304-3940(99)00578-9","article-title":"Oxidative damage to mitochondrial DNA in huntington\u2019s disease parietal cortex.","volume":"272","author":"Polidori","year":"1999","journal-title":"Neurosci. Lett."},{"key":"B120","doi-asserted-by":"publisher","first-page":"1792","DOI":"10.1093\/hmg\/ddw051","article-title":"Mitochondrial targeting of XJB-5-131 attenuates or improves pathophysiology in HdhQ150 animals with well-developed disease phenotypes.","volume":"25","author":"Polyzos","year":"2016","journal-title":"Hum. Mol. Genet."},{"key":"B121","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0194580","article-title":"XJB-5-131-mediated improvement in physiology and behaviour of the R6\/2 mouse model of Huntington\u2019s disease is age- and sex- dependent.","volume":"13","author":"Polyzos","year":"2018","journal-title":"PLoS One"},{"key":"B122","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1016\/S0968-0004(00)01674-1","article-title":"Mitochondria, oxygen free radicals, disease and ageing.","volume":"25","author":"Raha","year":"2000","journal-title":"Trends Biochem. Sci."},{"key":"B123","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1097\/01.wnr.0000081868.45938.12","article-title":"Ascorbate treatment attenuates the Huntington behavioral phenotype in mice.","volume":"14","author":"Rebec","year":"2003","journal-title":"Neuroreport"},{"key":"B124","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/j.neuroscience.2005.08.062","article-title":"Hyperactive striatal neurons in symptomatic Huntington R6\/2 mice: variations with behavioral state and repeated ascorbate treatment.","volume":"137","author":"Rebec","year":"2006","journal-title":"Neuroscience"},{"key":"B125","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.bbadis.2011.10.016","article-title":"Mutant huntingtin, abnormal mitochondrial dynamics, defective axonal transport of mitochondria, and selective synaptic degeneration in Huntington\u2019s disease.","volume":"1822","author":"Reddy","year":"2012","journal-title":"Biochim. Biophys. Acta"},{"key":"B126","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.redox.2016.11.004","article-title":"Inhibition of autophagy with bafilomycin and chloroquine decreases mitochondrial quality and bioenergetic function in primary neurons.","volume":"11","author":"Redmann","year":"2017","journal-title":"Redox. Biol."},{"key":"B127","doi-asserted-by":"publisher","first-page":"1929","DOI":"10.1007\/s00018-010-0305-y","article-title":"Downregulation of NF-kappaB signaling by mutant huntingtin proteins induces oxidative stress and cell death.","volume":"67","author":"Reijonen","year":"2010","journal-title":"Cell Mol. Life Sci."},{"key":"B128","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1016\/j.yexcr.2007.12.025","article-title":"Inhibition of endoplasmic reticulum stress counteracts neuronal cell death and protein aggregation caused by N-terminal mutant huntingtin proteins.","volume":"314","author":"Reijonen","year":"2008","journal-title":"Exp. Cell Res."},{"key":"B129","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/S1474-4422(18)30391-0","article-title":"Safety and efficacy of pridopidine in patients with Huntington\u2019s disease (PRIDE-HD): a phase 2, randomised, placebo-controlled, multicentre, dose-ranging study.","volume":"18","author":"Reilmann","year":"2019","journal-title":"Lancet Neurol."},{"key":"B130","doi-asserted-by":"publisher","first-page":"1857","DOI":"10.1016\/j.freeradbiomed.2012.09.004","article-title":"Glutathione redox cycle dysregulation in Huntington\u2019s disease knock-in striatal cells.","volume":"53","author":"Ribeiro","year":"2012","journal-title":"Free Radic. Biol. Med."},{"key":"B131","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1093\/toxsci\/kft199","article-title":"Oxidizing effects of exogenous stressors in Huntington\u2019s disease knock-in striatal cells\u2013protective effect of cystamine and creatine.","volume":"136","author":"Ribeiro","year":"2013","journal-title":"Toxicol. Sci."},{"key":"B132","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1038\/nrneurol.2014.24","article-title":"Huntington disease: natural history, biomarkers and prospects for therapeutics.","volume":"10","author":"Ross","year":"2014","journal-title":"Nat. Rev. Neurol."},{"key":"B133","doi-asserted-by":"publisher","first-page":"3032","DOI":"10.1073\/pnas.1314421111","article-title":"HACE1 reduces oxidative stress and mutant Huntingtin toxicity by promoting the NRF2 response.","volume":"111","author":"Rotblat","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B134","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1016\/j.bbadis.2012.11.018","article-title":"Quercetin supplementation is effective in improving mitochondrial dysfunctions induced by 3-nitropropionic acid: implications in Huntington\u2019s disease.","volume":"1832","author":"Sandhir","year":"2013","journal-title":"Biochim. Biophys. Acta"},{"key":"B135","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1016\/j.neuint.2010.07.005","article-title":"Lycopene prevents 3-nitropropionic acid-induced mitochondrial oxidative stress and dysfunctions in nervous system.","volume":"57","author":"Sandhir","year":"2010","journal-title":"Neurochem. Int."},{"key":"B136","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1159\/000334273","article-title":"N-Acetylcysteine reverses mitochondrial dysfunctions and behavioral abnormalities in 3-nitropropionic acid-induced Huntington\u2019s disease.","volume":"9","author":"Sandhir","year":"2012","journal-title":"Neurodegener. Dis."},{"key":"B137","doi-asserted-by":"publisher","first-page":"5641","DOI":"10.1074\/jbc.M609532200","article-title":"Trehalose, a novel mTOR-independent autophagy enhancer, accelerates the clearance of mutant huntingtin and alpha-synuclein.","volume":"282","author":"Sarkar","year":"2007","journal-title":"J. Biol. Chem."},{"key":"B138","doi-asserted-by":"publisher","first-page":"8843","DOI":"10.1073\/pnas.1608264113","article-title":"Transcriptional control of amino acid homeostasis is disrupted in Huntington\u2019s disease.","volume":"113","author":"Sbodio","year":"2016","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B139","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1073\/pnas.1717877115","article-title":"Golgi stress response reprograms cysteine metabolism to confer cytoprotection in Huntington\u2019s disease.","volume":"115","author":"Sbodio","year":"","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B140","doi-asserted-by":"publisher","first-page":"1450","DOI":"10.1089\/ars.2017.7321","article-title":"Redox mechanisms in neurodegeneration: from disease outcomes to therapeutic opportunities.","volume":"30","author":"Sbodio","year":"","journal-title":"Antioxid. Redox. Signal."},{"key":"B141","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1111\/bph.14446","article-title":"Regulators of the transsulfuration pathway.","volume":"176","author":"Sbodio","year":"","journal-title":"Br. J. Pharmacol."},{"key":"B142","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.molcel.2011.10.021","article-title":"Hydrogen sulfide-linked sulfhydration of NF-kappaB mediates its antiapoptotic actions.","volume":"45","author":"Sen","year":"2012","journal-title":"Mol. Cell"},{"key":"B143","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1038\/nrm3546","article-title":"The ATM protein kinase: regulating the cellular response to genotoxic stress, and more.","volume":"14","author":"Shiloh","year":"2013","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"B144","doi-asserted-by":"publisher","first-page":"1438","DOI":"10.1093\/hmg\/ddr024","article-title":"Abnormal mitochondrial dynamics, mitochondrial loss and mutant huntingtin oligomers in Huntington\u2019s disease: implications for selective neuronal damage.","volume":"20","author":"Shirendeb","year":"2011","journal-title":"Hum. Mol. Genet."},{"key":"B145","doi-asserted-by":"publisher","first-page":"1911","DOI":"10.1007\/s11011-018-0297-0","article-title":"Nicotinamide reverses behavioral impairments and provides neuroprotection in 3-nitropropionic acid induced animal model ofHuntington\u2019s disease: implication of oxidative stress- poly(ADP- ribose) polymerase pathway.","volume":"33","author":"Sidhu","year":"2018","journal-title":"Metab. Brain Dis."},{"key":"B146","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1146\/annurev-biochem-061516-045037","article-title":"Oxidative stress.","volume":"86","author":"Sies","year":"2017","journal-title":"Annu. Rev. Biochem."},{"key":"B147","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.1002\/glia.20526","article-title":"Ferritin accumulation in dystrophic microglia is an early event in the development of Huntington\u2019s disease.","volume":"55","author":"Simmons","year":"2007","journal-title":"Glia"},{"key":"B148","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1016\/j.bbadis.2006.03.004","article-title":"Dose ranging and efficacy study of high-dose coenzyme Q10 formulations in Huntington\u2019s disease mice.","volume":"1762","author":"Smith","year":"2006","journal-title":"Biochim. Biophys. Acta"},{"key":"B149","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1038\/nm.2313","article-title":"Mutant huntingtin binds the mitochondrial fission GTPase dynamin-related protein-1 and increases its enzymatic activity.","volume":"17","author":"Song","year":"2011","journal-title":"Nat. Med."},{"key":"B150","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/j.cell.2006.09.024","article-title":"Suppression of reactive oxygen species and neurodegeneration by the PGC-1 transcriptional coactivators.","volume":"127","author":"St-Pierre","year":"2006","journal-title":"Cell"},{"key":"B151","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1007\/s11011-016-9929-4","article-title":"Effect of rutin against a mitochondrial toxin, 3-nitropropionicacid induced biochemical, behavioral and histological alterations-a pilot study on Huntington\u2019s disease model in rats.","volume":"32","author":"Suganya","year":"2017","journal-title":"Metab. Brain Dis."},{"key":"B152","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1038\/nm985","article-title":"Trehalose alleviates polyglutamine-mediated pathology in a mouse model of Huntington disease.","volume":"10","author":"Tanaka","year":"2004","journal-title":"Nat. Med."},{"key":"B153","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/S0896-6273(03)00366-0","article-title":"Huntingtin and huntingtin-associated protein 1 influence neuronal calcium signaling mediated by inositol-(1,4,5) triphosphate receptor type 1.","volume":"39","author":"Tang","year":"2003","journal-title":"Neuron"},{"key":"B154","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1038\/nrd2803","article-title":"Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach?","volume":"8","author":"Trachootham","year":"2009","journal-title":"Nat. Rev. Drug Discov."},{"key":"B155","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1038\/nchembio.1308","article-title":"Proteostasis of polyglutamine varies among neurons and predicts neurodegeneration.","volume":"9","author":"Tsvetkov","year":"2013","journal-title":"Nat. Chem. Biol."},{"key":"B156","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1111\/j.1600-079X.2004.00163.x","article-title":"Protective effect of melatonin on 3-nitropropionic acid-induced oxidative stress in synaptosomes in an animal model of Huntington\u2019s disease.","volume":"37","author":"Tunez","year":"2004","journal-title":"J. Pineal. Res."},{"key":"B157","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2018.00500","article-title":"Drug repositioning for effective prostate cancer treatment.","volume":"9","author":"Turanli","year":"2018","journal-title":"Front. Physiol."},{"key":"B158","doi-asserted-by":"publisher","first-page":"3413","DOI":"10.1093\/hmg\/ddq253","article-title":"Antioxidants can inhibit basal autophagy and enhance neurodegeneration in models of polyglutamine disease.","volume":"19","author":"Underwood","year":"2010","journal-title":"Hum. Mol. Genet."},{"key":"B159","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1111\/j.1471-4159.2005.03357.x","article-title":"Cystamine treatment is neuroprotective in the YAC128 mouse model of Huntington disease.","volume":"95","author":"Van Raamsdonk","year":"2005","journal-title":"J. Neurochem."},{"key":"B160","doi-asserted-by":"publisher","first-page":"2094","DOI":"10.1073\/pnas.95.5.2094","article-title":"Codominant interference, antieffectors, and multitarget drugs.","volume":"95","author":"Varshavsky","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B161","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2017.00319","article-title":"The central role of amino acids in cancer redox homeostasis: vulnerability points of the cancer redox code.","volume":"7","author":"Vucetic","year":"2017","journal-title":"Front. Oncol."},{"key":"B162","doi-asserted-by":"publisher","first-page":"3070","DOI":"10.1074\/jbc.M112.407726","article-title":"Dysregulation of mitochondrial calcium signaling and superoxide flashes cause mitochondrial genomic DNA damage in Huntington disease.","volume":"288","author":"Wang","year":"2013","journal-title":"J. Biol. Chem."},{"key":"B163","doi-asserted-by":"publisher","first-page":"14496","DOI":"10.1523\/JNEUROSCI.3059-11.2011","article-title":"The melatonin MT1 receptor axis modulates mutant Huntingtin-mediated toxicity.","volume":"31","author":"Wang","year":"2011","journal-title":"J. Neurosci."},{"key":"B164","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/S0006-8993(99)02433-6","article-title":"Glutamate stimulates ascorbate transport by astrocytes.","volume":"858","author":"Wilson","year":"2000","journal-title":"Brain Res."},{"key":"B165","doi-asserted-by":"publisher","first-page":"3013","DOI":"10.1089\/ARS.2009.2541","article-title":"Redox-directed cancer therapeutics: molecular mechanisms and opportunities.","volume":"11","author":"Wondrak","year":"2009","journal-title":"Antioxid. Redox. Signal."},{"key":"B166","doi-asserted-by":"publisher","first-page":"2923","DOI":"10.1093\/hmg\/ddw144","article-title":"N-acetylcysteine modulates glutamatergic dysfunction and depressive behavior in Huntington\u2019s disease.","volume":"25","author":"Wright","year":"2016","journal-title":"Hum. Mol. Genet."},{"key":"B167","doi-asserted-by":"publisher","DOI":"10.1038\/tp.2014.131","article-title":"N-Acetylcysteine improves mitochondrial function and ameliorates behavioral deficits in the R6\/1 mouse model of Huntington\u2019s disease.","volume":"5","author":"Wright","year":"2015","journal-title":"Transl. Psychiatry"},{"key":"B168","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1016\/j.celrep.2012.10.001","article-title":"Targeting of XJB-5-131 to mitochondria suppresses oxidative DNA damage and motor decline in a mouse model of Huntington\u2019s disease.","volume":"2","author":"Xun","year":"2012","journal-title":"Cell Rep."},{"key":"B169","doi-asserted-by":"publisher","first-page":"1427","DOI":"10.1111\/j.1471-4159.2009.06074.x","article-title":"Combination therapy with coenzyme Q10 and creatine produces additive neuroprotective effects in models of Parkinson\u2019s and Huntington\u2019s diseases.","volume":"109","author":"Yang","year":"2009","journal-title":"J. Neurochem."},{"key":"B170","doi-asserted-by":"publisher","first-page":"1739","DOI":"10.1093\/hmg\/ddw045","article-title":"Mitochondria-targeted molecules MitoQ and SS31 reduce mutant huntingtin-induced mitochondrial toxicity and synaptic damage in Huntington\u2019s disease.","volume":"25","author":"Yin","year":"2016","journal-title":"Hum. Mol. Genet."}],"container-title":["Frontiers in Molecular Neuroscience"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fnmol.2019.00068\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,21]],"date-time":"2019-11-21T16:21:58Z","timestamp":1574353318000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fnmol.2019.00068\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3,19]]},"references-count":170,"alternative-id":["10.3389\/fnmol.2019.00068"],"URL":"https:\/\/doi.org\/10.3389\/fnmol.2019.00068","relation":{},"ISSN":["1662-5099"],"issn-type":[{"value":"1662-5099","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,3,19]]},"article-number":"68"}}